INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on August 1, 2025, covering an event that occurred on July 28, 2025. The company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol "IVF".
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The specific financial activity reported is a capital raise:
- Cash Raised: $200,000
- Instrument: 200 shares of Series C-2 Convertible Preferred Stock
- Transaction Type: Exercise of Additional Investment Right by an institutional investor and existing holder.
Material Changes
The primary material change is the adjustment of the conversion price for the Series C-2 Convertible Preferred Stock. Following the July 28, 2025 transaction, the conversion price adjusted to $1.8909 per share. The shares were issued without registration under the Securities Act, relying on exemptions under Section 4(a)(2) and Rule 506.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure regarding the unregistered nature of the securities sale. The transaction was executed pursuant to a Securities Purchase Agreement dated January 3, 2024, to which the Company became a party via a joinder agreement on October 11, 2024.
Investor Verification Checklist
- Verify the impact of the new $1.8909 conversion price on existing Series C-2 Preferred Stock holders.
- Confirm the identity of the institutional investor exercising the Additional Investment Right.
- Review the full text of the Securities Purchase Agreement (dated Jan 3, 2024) and the Joinder Agreement (dated Oct 11, 2024) for further terms.
- Check subsequent filings for the issuance of common stock upon conversion of these preferred shares.